DIAPH3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.613300E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.541200E-01
Normal-vs-Stage2
4.787800E-04
Normal-vs-Stage3
4.303800E-01
Normal-vs-Stage4
1.300650E-01
Stage1-vs-Stage2
2.054800E-01
Stage1-vs-Stage3
7.249000E-01
Stage1-vs-Stage4
4.777600E-01
Stage2-vs-Stage3
4.790600E-01
Stage2-vs-Stage4
6.557800E-01
Stage3-vs-Stage4
7.632000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.816200E-04
Normal-vs-AfricanAmerican
2.980400E-01
Normal-vs-Asian
5.693800E-02
Caucasian-vs-AfricanAmerican
7.597000E-01
Caucasian-vs-Asian
5.542800E-01
AfricanAmerican-vs-Asian
3.995800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.587600E-04
Normal-vs-Female
1.207190E-04
Male-vs-Female
4.483600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.385000E-01
Normal-vs-Age(41-60Yrs)
1.669950E-01
Normal-vs-Age(61-80Yrs)
6.646100E-04
Normal-vs-Age(81-100Yrs)
8.709600E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.260400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.254600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.243200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.575400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.603800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.199600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.262600E-03
Normal-vs-Daily Drinker
3.238200E-01
Normal-vs-Weekly Drinker
1.088070E-02
Normal-vs-Occasional Drinker
6.024200E-03
Normal-vs-Social Drinker
1.263790E-01
Non Drinker-vs-Daily Drinker
2.095600E-01
Non Drinker-vs-Weekly Drinker
4.448600E-01
Non Drinker-vs-Occasional Drinker
6.963400E-01
Non Drinker-vs-Social Drinker
9.521200E-01
Daily Drinker-vs-Weekly Drinker
8.853500E-02
Daily Drinker-vs-Occasional Drinker
1.087190E-01
Daily Drinker-vs-Social Drinker
1.186440E-01
Weekly Drinker-vs-Occasional Drinker
6.787400E-01
Weekly Drinker-vs-Social Drinker
4.498600E-01
Occasional Drinker-vs-Social Drinker
7.234200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.066400E-01
Normal-vs-Grade 2
7.061200E-01
Normal-vs-Grade 3
7.293200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.719300E-03
Grade 1-vs-Grade 3
1.559340E-03
Grade 1-vs-Grade 4
6.066400E-01
Grade 2-vs-Grade 3
5.275800E-01
Grade 2-vs-Grade 4
7.061200E-01
Grade 3-vs-Grade 4
7.293200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.222310E-02
Normal-vs-NonDiabetic
1.611310E-04
Diabetic-vs-NonDiabetic
2.843000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.009170E-01
Normal-vs-NoPancreatitis
4.187500E-04
Pancreatitis-vs-NoPancreatitis
9.549000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.963700E-04
Normal-vs-N1
6.980800E-04
N0-vs-N1
8.351600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.45620000502333E-08
Normal-vs-TP53-NonMutant
8.300200E-03
TP53-Mutant-vs-TP53-NonMutant
3.16850000003921E-06
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
